https://s3-us-west-2.amazonaws.com/secure.notion-static.com/2be03e38-0363-4c08-8bf7-da1da1a7df22/1-s2.0-S0169409X08002652-main.pdf
Bulk Viscosity of mucus is typically 1000-10000 times that of water.
Mucus gels are loaded with bacteria, cells, lipids, salts, proteins, macromolecules, and cellular debris. 90-98% of mucus is water.
Viscoelasticity is regulated by controlling water: mucin secretion ratio.
and also by controlling lipid ion content. (mucus rheology [47])
viscoelasticity increases with acidity. pH of the lung and nasal mucus is neutral


The understanding of mucus layer thickness and clearance times at various mucosal surfaces is important to the development of particles designed to overcome mucosal clearance mechanisms, since they must penetrate mucus at rates markedly faster than mucus renewal and clearance in order to overcome the barrier.
if the viscosity of the fluid that fills the pores in mucus is equivalent to that of water, the diffusion rates of particulates significantly smaller than the average mucus mesh pore size, assuming they do not adhere to mucus, are expected to be similar to their rates in water.
The obstruction scaling model assumes the average pore size to be 100 nm.
Therefore the size of the Mucus Penetrating Particles must be < 100 nm
Working of mucus as a sticky net:
Foreign particles smaller than average pore size might be stopped nevertheless if the particles have high viscidity and thus are more attracted towards hydrophobic interactions. This would even dominate the effect of negative negative repulsion between proteoglycans and the foreign particles.
The dual capacity to form polyvalent adhesive interactions via both hydrophobic and anionic forces represents a particularly challenging problem for polymeric nanoparticles designed to deliver drugs and genes, since many commonly used biomaterials are either hydrophobic, such as poly (lactide–co-glycolide) and polyanhydrides, or cationic, such as polyethylenimine, chitosan and polylysine

inspiration from viruses
Required polymer:
PEGylation
The rapid mucosal transport of large (200 and 500 nm) PEG- modified particles has important implications for the development of therapeutic and imaging applications in vivo.
Larger nanoparticles afford substantially higher drug encapsulation as well as reduced aggregation upon freeze drying.
As the size of drug-loaded particles increases, the drug-release kinetics are usually greatly improved as well, allowing sustained release of therapeutics over days and even months along with enhanced therapeutic efficacy